Xylos Corporation, is a biomaterials-based medical device company with a platform technology based on biocellulose. Xylos is dedicated to delivering superior biomaterials solutions for the treatment, repair and replacement of human tissue without the shortfalls associated with tissue harvested from human and animal origins and materials from synthetic sources. Xylosâ proprietary biocellulose technology possesses the effectiveness, versatility and safety profile to address a broad range of medical applications including surgical implants for musculoskeletal, urological / gynecological, general, abdominal, cardiovascular and plastic / aesthetics indications representing a U.S. market opportunity of approximately $4 billio
